It seems as if every orthopedic device company is getting involved in robot-assisted surgery — rolling out robots to assist surgeons operating on the knee, hip, shoulder or spine.
Two events in recent years especially signaled that robots were coming into their own in the space: Stryker spent $1.7 billion for Mako Surgical in order to sell robotic systems to aid knee and hip replacement surgeries, and Medtronic acquired Mazor Robotics for $1.7 billion so that it could expand into the robot-assisted spine surgery space.
Now all of the other big ortho device companies have either launched or are preparing to launch their own robots.
“Even if not necessarily proven to be better medicine, you can’t afford not to have an answer to robotics,” SVB Leerink analyst Richard Newitter recently told Medical Design & Outsourcing. “There’s a strategy now where having a robot is better than not having a robot.”
A growth-driven and strategic executive, Peter Coffaro commands more than 25 years of progressive management success within the medical device industry. Recognized by the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com as one of the top medical sales influencers in the industry; he has 10 years of combined sales management experience and has held positions as a Director, General Manager, Distributor, and Vice President. Peter has worked for some of the top orthopedic companies in the world - Zimmer, DePuy, and Stryker. He is also the founder of OrthoFeed: a popular blog that covers digital orthopedic news and emerging medical technologies. Peter is a three-time Hall of Fame award winner at Johnson and Johnson and has an extensive background in organizational development, business development, sales management, digital marketing, and professional education. Peter holds a B.S. degree in Biology and Chemistry from Northern Illinois University.
(MassDevice) – Stryker’s success with its Mako robot-assisted surgery platform has other orthopedic device companies hastening to enter the space. The big question is whether long-term outcomes will justify the expensive technology. […]
(Bloomberg) – Johnson & Johnson, the world’s largest maker of health-care products, is pursuing an acquisition of Auris Health Inc. in a deal that would bring it cutting-edge surgical robotics technology, people with knowledge of the matter said. […]
Be the first to comment